Literature DB >> 6298944

Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.

E F Harrison, J E Hawke, H L Hunter, J J Costanzi, L R Morgan, D Plotkin, W G Tucker, P M Worrall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6298944

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  11 in total

Review 1.  Chemotherapy in non-small cell lung cancer.

Authors:  C J Sweeney; A B Sandler
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

2.  Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.

Authors:  J Banks; E G Anderson; A P Smith
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Chemotherapy in non-small cell bronchial carcinoma.

Authors:  R Souhami
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

4.  Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.

Authors:  N Thatcher; H Anderson; D B Smith; W P Steward; K Webb; A Hilton; A Rahman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.

Authors:  F Kanzawa; Y Matsushima; A Hoshi; E Shimizu; N Saijo; N Miyazawa
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

6.  Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.

Authors:  S D Chetiyawardana; M H Cullen; R C Joshi; C M Woodroffe
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  A phase II study of ifosfamide in children with recurrent solid tumours.

Authors:  C R Pinkerton; H Rogers; C James; A Bowman; P R Barbor; O B Eden; J Pritchard
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 8.  Lung cancer in the elderly: current and future chemotherapeutic options.

Authors:  Stuart Hinton; Alan Sandler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 9.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  A phase II study of ifosfamide in paediatric solid tumours.

Authors:  C R Pinkerton; J Pritchard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.